3 days popular7 days popular1 month popular3 months popular

Muscular Dystrophy Therapies Reviewed

Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine. “This is a focus article in which we summarize the impact of MG53 protein therapy [...]